Overview
Etoricoxib is a highly selective COX-2 inhibitor, a specialized class of nonsteroidal anti-inflammatory drugs (NSAIDs). It is renowned for providing potent and rapid relief from pain and inflammation. It is frequently prescribed for managing chronic joint conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and for the acute treatment of severe gout attacks.

Mechanism of Action
Unlike traditional NSAIDs that block both COX-1 and COX-2 enzymes, etoricoxib selectively targets the COX-2 enzyme. This enzyme is specifically responsible for producing prostaglandins that trigger pain and inflammation. By sparing the COX-1 enzyme, which protects the stomach lining, etoricoxib delivers strong anti-inflammatory effects while significantly reducing the likelihood of gastrointestinal complications.

Dosage and Administration
The dosage varies strictly depending on the condition being treated. For osteoarthritis, the usual dose is 30 mg or 60 mg once daily. For rheumatoid arthritis and ankylosing spondylitis, it is typically 90 mg once daily. For acute gout, a higher dose of 120 mg once daily is used, but strictly limited to a maximum of 8 days. It can be taken with or without food.

Side Effects
While it offers gastrointestinal protection, it is not entirely risk-free. Common side effects may include dizziness, headache, and mild digestive upset. More importantly, like all COX-2 inhibitors, etoricoxib carries a significant warning for potential cardiovascular risks, particularly with long-term use or at high doses, which may increase the chance of heart attacks or strokes.

Contraindications
Etoricoxib is strictly contraindicated in patients with established ischemic heart disease, peripheral arterial disease, or a history of stroke. It should not be used by individuals with uncontrolled hypertension or severe liver and kidney impairment.

Pregnancy and Lactation
The use of etoricoxib is strongly discouraged during pregnancy, especially in the third trimester, due to risks to fetal development. It is also contraindicated during breastfeeding, as the drug may pass into breast milk and affect the infant.